Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Perimeter Solutions | PRM | Nov 25, 2024 | 13.11 | -0.15 |
Perion Network | PERI | Nov 25, 2024 | 8.55 | +0.35 |
Perma-Fix Environmental Services | PESI | Nov 25, 2024 | 13.46 | -6.66 |
Perma-Pipe International | PPIH | Nov 25, 2024 | 15.27 | -0.52 |
Permian Basin Royalty Trust | PBT | Nov 25, 2024 | 12.83 | -7.43 |
Permian Resources | PR | Nov 25, 2024 | 15.68 | -3.27 |
Permianville Royalty Trust Unit | PVL | Nov 25, 2024 | 1.55 | 0.00 |
PermRock Royalty Trust Unit | PRT | Nov 25, 2024 | 3.98 | -1.00 |
Perpetua Resources | PPTA | Nov 25, 2024 | 9.36 | -5.26 |
Perrigo | PRGO | Nov 25, 2024 | 28.40 | +1.18 |
Personalis | PSNL | Nov 25, 2024 | 3.60 | +3.75 |
Perspective Therapeutics | CATX | Nov 25, 2024 | 3.69 | +6.34 |
Petco Health And Wellness | WOOF | Nov 25, 2024 | 4.23 | +1.44 |
PetIQ A | PETQ | Nov 25, 2024 | 30.98 | 0.00 |
PetMed Express | PETS | Nov 25, 2024 | 4.76 | -0.42 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Nov 25, 2024 | 14.79 | -0.74 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Nov 25, 2024 | 13.52 | -0.52 |
Petros Pharmaceuticals | PTPI | Nov 25, 2024 | 0.29 | +7.45 |
Pfizer | PFE | Nov 25, 2024 | 26.17 | +2.03 |
Pgim Global High Yield Fund | GHY | Nov 25, 2024 | 12.84 | -0.47 |
Pgim High Yield Bond Fund | ISD | Nov 25, 2024 | 13.82 | -0.43 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Nov 25, 2024 | 16.65 | +0.30 |
Pharmaceutical ETF Market Vectors | PPH | Nov 25, 2024 | 88.78 | +0.23 |
PharmaCyte Biotech | PMCB | Nov 25, 2024 | 1.72 | +1.18 |
Pharming Group ADR | PHAR | Nov 25, 2024 | 7.65 | +1.59 |
Pharvaris | PHVS | Nov 25, 2024 | 23.69 | +6.28 |
Phathom Pharmaceuticals | PHAT | Nov 25, 2024 | 9.09 | -2.68 |
PhenixFIN | PFX | Nov 25, 2024 | 46.75 | +1.02 |
Pheton | PTHL | Nov 25, 2024 | 4.36 | 0.00 |
Phibro Animal Health A | PAHC | Nov 25, 2024 | 24.14 | +1.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.